{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T14:18:57Z","timestamp":1697984337938},"reference-count":42,"publisher":"Wiley","issue":"S335","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":7296,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1987,9]]},"abstract":"<jats:p>For two decades it has been hypothesized that schizophrenia and depression are related to alterations in the activity of specific neurotransmitters in brain; to a great extent, these theories are based on the assumed mode of action of antipsychotic and antidepressant drugs. With the available knowledge of how panic anxiety can be effectively treated (and elicited) with drugs, it is now reasonable to formulate hypotheses also regarding the contribution of central neurotransmitters to the generation of panic. As will be discussed in this brief review, three substances seem to be of particular importance in this context: serotonin, noradrenaline and GABA. In view of this concept, the putative mode of action of the atypical benzodiazepine derivative alprazolam, which in contrast to other benzodiazepines has been attributed effectiveness in the treatment of panic, will also be discussed.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1987.tb07746.x","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T10:53:13Z","timestamp":1187866393000},"page":"31-37","source":"Crossref","is-referenced-by-count":17,"title":["Brain neurotransmission in panic disorder"],"prefix":"10.1111","volume":"76","author":[{"given":"Elias","family":"Eriksson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-198601000-00002"},{"key":"e_1_2_1_3_2","first-page":"64","volume-title":"The borderline between anxiety and depression","author":"Eriksson E.","year":"1986"},{"key":"e_1_2_1_4_2","unstructured":"GlogerS. GladicD. O'RyanF. CodnerS. CohenL.Panic attacks and agoraphobia: low dose clomipramine treatment.Presented at the IVth World Congress of Biological Psychiatry 1985;Abstr No 129:8."},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00464571"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198404020-00002"},{"key":"e_1_2_1_7_2","unstructured":"AlexanderDE AlexanderDD.Alprazolam treatment for panic disorder.Presented at the 137th Annual Meeting at The American Psychiatric Association Los Angeles May1984."},{"key":"e_1_2_1_8_2","unstructured":"BallengerJC RubinRT DuPontRLet al.Treatment of agoraphobia\/panic disorder with alprazolam. Preliminary results from a large multicenter placebo\u2010controlled trial. Presented at the Annual NCDEU Meeting Key Biscayne.April 1985."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03330460039029"},{"key":"e_1_2_1_10_2","first-page":"751","article-title":"Panic induced elevation of plasma MHPG levels in phobic\u2010anxious patients","volume":"41","author":"Ko GN","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(85)90046-1"},{"key":"e_1_2_1_12_2","first-page":"69","volume-title":"Anxiety: New research and changing concepts","author":"McNair MM","year":"1981"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00429653"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1986.tb02666.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1980.01780140053006"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1972.tb06846.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1974.01760100019004"},{"key":"e_1_2_1_18_2","unstructured":"\u00c5grenH.Biological markers in major depressive disorders: a clinical and multivariate study 1981. (Thesis)."},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01670278"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(85)90022-8"},{"key":"e_1_2_1_21_2","first-page":"551","article-title":"Panic disorder and major depression: Biological relationships","volume":"21","author":"Roy\u2010Byrne PP","year":"1985","journal-title":"Psychopharm Bull"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01244101"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(84)90099-6"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(77)90499-1"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(75)90881-1"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(76)90498-4"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00592678"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1984.01790190025003"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1985.01790260027003"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(82)90406-X"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01955287"},{"key":"e_1_2_1_32_2","first-page":"233","article-title":"Mianserin: direct activation of brain notepinephrine neurons by blocking alpha2\u2010receptors","volume":"4","author":"Engberg G.","year":"1980","journal-title":"Comm Psychopharm"},{"key":"e_1_2_1_33_2","unstructured":"SvenssonTH EngbergG.Effect of nicotine on single cell activity in the noradrenergic nucleus locus coeruleus.Acta Psych Scand1980;suppl 479:31\u20134."},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.143.4.483"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01254925"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90363-1"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(84)90583-6"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92277-8"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3892688"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(85)72752-1"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(84)90247-4"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(86)90562-X"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00652229"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1987.tb07746.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1987.tb07746.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T13:53:13Z","timestamp":1697896393000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1987.tb07746.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,9]]},"references-count":42,"journal-issue":{"issue":"S335","published-print":{"date-parts":[[1987,9]]}},"alternative-id":["10.1111\/j.1600-0447.1987.tb07746.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1987.tb07746.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,9]]}}}